Research investigates novel inhibitors and probes targeting arginine methyltransferases, suggesting therapeutic potential for cancer.
Arginine methyltransferases (PRMTs) are key regulators of chromatin structure, RNA processing, and signal transduction, and their dysregulation has been linked to cancer and other diseases. The development of potent and...
No takes yet. Share an insight, caveat, or question.
Yoshisada et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: